Drug Discovery and Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Voices
    • Views
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE

Pittcon 2009 Announces 20th Annual James L. Waters Symposium

By Drug Discovery Trends Editor | January 29, 2009

The Pittsburgh Conference announces, ‘Near Infrared Spectroscopy -NIRS,’ as the topic for the twentieth annual James L. Waters Annual Symposium. The 2009 Waters Symposium will be presented at Pittcon 2009 (March 8-13, 2009) in Chicago, Illinois, Room S401d of McCormick Place South, Monday, March 9, 2009, 1:30 to 4:30 p.m.

The twentieth annual Waters Symposium recognizes the important technological contribution of Near Infrared Spectroscopy (NIRS) to the world of analytical chemistry. An outstanding panel of speakers has been organized to recognize and review the development, widespread commercial application, and current research in NIRS.

The Society of Analytical Chemists of Pittsburgh (SACP) is extremely pleased to welcome the following NIRS pioneers to Pittcon 2009.

  • Peter Flinn, Kelspec Services Pty. Ltd., ‘Near Infrared Spectroscopy: From Sleeper to Activist’
  • Karl Norris, U.S. Department of Agriculture (USDA), ‘In the Beginning Was: Visible and IR Spectroscopy’
  • Franklin Barton, Agricultural Research Service (ARS) agency of the USDA, ‘NIR-A Journey in Learning’
  • Phil Williams, PDK Grain, ‘The Introduction of Near-infrared Spectroscopy to the World of Commerce’
  • Robert A. Lodder, University of Kentucky Medical Center, ‘Modern Applications of Near-Infrared Spectrometry’

For more information about Pittcon 2009 or the James L. Waters Annual Symposium please visit www.pittcon.org.

Release Date: January 6, 2009
Source: Pittcon


Filed Under: Drug Discovery

 

Related Articles Read More >

Bayer’s Lynkuet approved by FDA for menopausal hot flashes
How stereo-correct data can de-risk AI-driven drug discovery
eConsent as the digital foundation for modern clinical trials 
Female Patient Being Reassured By Doctor In Hospital Room
Q&A: Thermo Fisher’s Luke Wilson on hitting 100% dose delivery with patient-centric supply
“ddd
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in the drug discovery and development industry.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Drug Discovery and Development
  • MassDevice
  • DeviceTalks
  • Medtech100 Index
  • Medical Design Sourcing
  • Medical Design & Outsourcing
  • Medical Tubing + Extrusion
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Pharmaceutical Processing World

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Drug Discovery & Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Voices
    • Views
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE